Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated about 14 hours ago
Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 19, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation...
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Date of authorisation: 18/09/2026, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Date...
Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Date of authorisation: 21/09/2026, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Date of authorisation...
Human medicines European public assessment report (EPAR): Jorveza, budesonide, Date of authorisation: 08/01/2018, Revision: 8, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Jorveza, budesonide, Date of authorisation...
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 10, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of...
Human medicines European public assessment report (EPAR): Relistor, methylnaltrexone bromide, Date of authorisation: 01/07/2008, Revision: 22, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Relistor, methylnaltrexone bromide, Date of...
Human medicines European public assessment report (EPAR): Degevma, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Degevma, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan), atazanavir, Date of authorisation: 22/08/2016, Revision: 22, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan)...
Human medicines European public assessment report (EPAR): Givlaari, givosiran, Date of authorisation: 02/03/2020, Revision: 8, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Givlaari, givosiran, Date of authorisation...
Sponsor guidance: New safety module on the annual safety report
about 17 hours ago
Sponsor guidance: New safety module on the annual safety report